Evista to prevent breast cancer

May 2006

More women will be taking Evista to prevent breast cancer.

New evidence shows that Evista (raloxifene) really does work as well as tamoxifen to reduce the risk of invasive breast cancer in postmenopausal women...and it's better tolerated.

Both drugs cut the risk of invasive breast cancer in half.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Medication Therapy Management (MTM) in conjunction with the new Medicare law
Women's Health Evista to prevent breast cancer
Women's Health Fem-V, a new at-home test to help determine how to treat vaginal infections
strategies for treatment-resistant depression
whether all ADHD drugs will get a black box warning about the risk of cardiac and psychiatric events
Obesity & Weight Loss using the new diabetes drug, Byetta (exenatide), for weight loss
Ophthalmology Soft contact lens users are getting warnings about serious fungal eye infections and some ReNu solutions
Infectious Diseases Truvada (tenofovir/emtricitabine) BEFORE risky behavior to prevent HIV infection
Cardiology Patients are asking if they should stop taking the combination of Plavix (clopidogrel) plus aspirin
Cardiology how to prevent or delay hypertension
Cardiology if chocolate is healthy
Gastroenterology levofloxacin-based regimens for treatment-resistant H. pylori infections
Medication Errors medication reconciliation
Pharmacists are having trouble stocking albuterol inhalers
Practice Niaspan and Niacor are no longer excluded under Medicare Part D

Evista to prevent breast cancer

Practical advice for a better career, with unlimited access to CE

Table of Contents